<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Genet</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosgen</journal-id><journal-title-group><journal-title>PLoS Genetics</journal-title></journal-title-group><issn pub-type="ppub">1553-7390</issn><issn pub-type="epub">1553-7404</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4595296</article-id><article-id pub-id-type="pmid">26439621</article-id><article-id pub-id-type="doi">10.1371/journal.pgen.1005520</article-id><article-id pub-id-type="publisher-id">PGENETICS-D-15-01326</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>FLCN and AMPK Confer Resistance to Hyperosmotic Stress via Remodeling of Glycogen Stores</article-title><alt-title alt-title-type="running-head">FLCN/AMPK Regulates Hyperosmotic Stress Resistance in <italic>C. elegans</italic></alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Possik</surname><given-names>Elite</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ajisebutu</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Manteghi</surname><given-names>Sanaz</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gingras</surname><given-names>Marie-Claude</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Vijayaraghavan</surname><given-names>Tarika</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Flamand</surname><given-names>Mathieu</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Coull</surname><given-names>Barry</given-names></name><xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Schmeisser</surname><given-names>Kathrin</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Duchaine</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>van Steensel</surname><given-names>Maurice</given-names></name><xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref><xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hall</surname><given-names>David H.</given-names></name><xref ref-type="aff" rid="aff005">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Pause</surname><given-names>Arnim</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label><addr-line>Goodman Cancer Research Center, McGill University, Montr&#x000e9;al, Qu&#x000e9;bec, Canada</addr-line></aff><aff id="aff002"><label>2</label><addr-line>Department of Biochemistry, McGill University, Montr&#x000e9;al, Qu&#x000e9;bec, Canada</addr-line></aff><aff id="aff003"><label>3</label><addr-line>College of Life Sciences, University of Dundee, Dundee, United Kingdom</addr-line></aff><aff id="aff004"><label>4</label><addr-line>Institute of Medical Biology, Singapore, Singapore</addr-line></aff><aff id="aff005"><label>5</label><addr-line>Department of Neuroscience, Albert Einstein College of Medicine, New York, New York, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Nutt</surname><given-names>Leta</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>St. Jude Children's Research Hospital, United States of America</addr-line></aff><author-notes><fn fn-type="conflict" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con" id="contrib001"><p>Conceived and designed the experiments: EP AP. Performed the experiments: EP AA SM BC MCG. Analyzed the data: EP AP MvS DHH SM. Contributed reagents/materials/analysis tools: EP AP MF TD KS TV DHH. Wrote the paper: EP AP.</p></fn><corresp id="cor001">* E-mail: <email>arnim.pause@mcgill.ca</email></corresp></author-notes><pub-date pub-type="epub"><day>6</day><month>10</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>10</month><year>2015</year></pub-date><volume>11</volume><issue>10</issue><elocation-id>e1005520</elocation-id><history><date date-type="received"><day>1</day><month>6</month><year>2015</year></date><date date-type="accepted"><day>21</day><month>8</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; 2015 Possik et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Possik et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="pgen.1005520.pdf"/><abstract><p>Mechanisms of adaptation to environmental changes in osmolarity are fundamental for cellular and organismal survival. Here we identify a novel osmotic stress resistance pathway in <italic>Caenorhabditis elegans (C</italic>. <italic>elegans)</italic>, which is dependent on the metabolic master regulator 5&#x02019;-AMP-activated protein kinase (AMPK) and its negative regulator Folliculin (FLCN). FLCN-1 is the nematode ortholog of the tumor suppressor FLCN, responsible for the Birt-Hogg-Dub&#x000e9; (BHD) tumor syndrome. We show that <italic>flcn-1</italic> mutants exhibit increased resistance to hyperosmotic stress via constitutive AMPK-dependent accumulation of glycogen reserves. Upon hyperosmotic stress exposure, glycogen stores are rapidly degraded, leading to a significant accumulation of the organic osmolyte glycerol through transcriptional upregulation of glycerol-3-phosphate dehydrogenase enzymes (<italic>gpdh-1</italic> and <italic>gpdh-2</italic>). Importantly, the hyperosmotic stress resistance in <italic>flcn-1</italic> mutant and wild-type animals is strongly suppressed by loss of AMPK, glycogen synthase, glycogen phosphorylase, or simultaneous loss of <italic>gpdh-1</italic> and <italic>gpdh-2</italic> enzymes. Our studies show for the first time that animals normally exhibit AMPK-dependent glycogen stores, which can be utilized for rapid adaptation to either energy stress or hyperosmotic stress. Importantly, we show that glycogen accumulates in kidneys from mice lacking FLCN and in renal tumors from a BHD patient. Our findings suggest a dual role for glycogen, acting as a reservoir for energy supply and osmolyte production, and both processes might be supporting tumorigenesis.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>The ability of an organism to adapt to sudden changes in environmental osmolarity is critical to ensure growth, propagation, and survival. The synthesis of organic osmolytes is a common adaptive strategy to survive hyperosmotic stress. However, it was not well understood, which biosynthetic pathways and storage strategies were used by organisms to rapidly generate osmolytes upon acute hyperosmotic stress. Here, we demonstrate that glycogen is an essential reservoir that is used upon acute hyperosmotic stress to generate the organic osmolyte glycerol promoting fast and efficient protection. Importantly, we show that this pathway is regulated by FLCN-1, an ortholog of the human tumor suppressor Folliculin responsible for the Birt-Hogg-Dub&#x000e9; cancer syndrome, and by AMPK, the master regulator of energy homeostasis.</p></abstract><funding-group><funding-statement>This work was supported by grants to AP from Myrovlytis Trust and Terry Fox Research Foundation. We acknowledge salary support to EP from the Rolande and Marcel Gosselin Graduate Studentship and the CIHR/FRSQ training grant in cancer research of the McGill Integrated Cancer Research Training Program (MICRTP). We acknowledge salary support to SM from MICRTP (CIHR/FRSQ-FRN53888) and to TV from the McGill-Canderel studentship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="6"/><table-count count="0"/><page-count count="18"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Water is a fundamental molecule for life and the ability of an organism to adapt to changes in water content is essential to ensure survival. Hyperosmotic stress promotes water efflux, causing cellular shrinkage, protein and DNA damage, cell cycle arrest and cell death. All living organisms encounter hyperosmotic environments [<xref rid="pgen.1005520.ref001" ref-type="bibr">1</xref>,<xref rid="pgen.1005520.ref002" ref-type="bibr">2</xref>]. In humans, both renal and non renal tissues are exposed to hyperosmotic stress, a condition that is regarded as a major cause for many chronic and fatal human diseases including diabetes, inflammatory bowel disease, hypernatremia, dry eye syndrome, and cancer [<xref rid="pgen.1005520.ref001" ref-type="bibr">1</xref>]. Cells/tissues/organisms have evolved adaptive strategies to cope with threatening hyperosmotic environments [<xref rid="pgen.1005520.ref001" ref-type="bibr">1</xref>,<xref rid="pgen.1005520.ref002" ref-type="bibr">2</xref>]. Among adaptive strategies, the synthesis of compatible organic osmolytes, which keeps cellular osmotic pressure equal to that of the external environment, is widely used by all organisms [<xref rid="pgen.1005520.ref003" ref-type="bibr">3</xref>]. In yeast and <italic>C</italic>. <italic>elegans</italic>, hyperosmotic stress triggers glycerol production via transcriptional upregulation of glycerol-3-phosphate dehydrogenase-1 <italic>(gpdh-1)</italic>, a rate-limiting enzyme in glycerol synthesis [<xref rid="pgen.1005520.ref004" ref-type="bibr">4</xref>,<xref rid="pgen.1005520.ref005" ref-type="bibr">5</xref>]. Moreover, several osmotic stress resistance mutants of divergent signaling pathways exhibit a constitutive transcriptional upregulation of <italic>gpdh-1</italic>, leading to increased glycerol content [<xref rid="pgen.1005520.ref006" ref-type="bibr">6</xref>&#x02013;<xref rid="pgen.1005520.ref010" ref-type="bibr">10</xref>].</p><p>Here we define a novel hyperosmotic stress resistance pathway mediated by the 5' AMP-activated protein kinase (AMPK), a key regulator of cellular energy balance [<xref rid="pgen.1005520.ref011" ref-type="bibr">11</xref>], which is chronically inactivated by the worm ortholog of the renal tumor suppressor Folliculin (FLCN-1). In humans, <italic>FLCN</italic> is a tumor suppressor gene responsible for the BHD disease, an autosomal dominantly-inherited syndrome associated with increased susceptibility to the development of several cancerous and non cancerous lesions including kidney cancer, pulmonary, renal, pancreatic and hepatic cysts and skin fibrofolliculomas [<xref rid="pgen.1005520.ref012" ref-type="bibr">12</xref>&#x02013;<xref rid="pgen.1005520.ref025" ref-type="bibr">25</xref>]. FLCN has been shown to bind AMPK via the scaffold FLCN-interacting proteins FNIP1 and FNIP2 [<xref rid="pgen.1005520.ref026" ref-type="bibr">26</xref>,<xref rid="pgen.1005520.ref027" ref-type="bibr">27</xref>]. We have recently demonstrated that FLCN negatively regulates AMPK signaling in the nematode <italic>C</italic>. <italic>elegans</italic> and in mammalian cells [<xref rid="pgen.1005520.ref028" ref-type="bibr">28</xref>,<xref rid="pgen.1005520.ref029" ref-type="bibr">29</xref>]. Moreover, loss of FLCN increased ATP levels via heightened flux of glycolysis, oxidative phosphorylation, and autophagy, which resulted in an AMPK-dependent resistance to several metabolic stresses in <italic>C</italic>. <italic>elegans</italic> and mammalian cells [<xref rid="pgen.1005520.ref028" ref-type="bibr">28</xref>,<xref rid="pgen.1005520.ref029" ref-type="bibr">29</xref>].</p><p>Here we identify a pathway involved in the physiological response to hyperosmotic stress resistance in <italic>C</italic>. <italic>elegans</italic> mediated by FLCN-1 and AMPK. We demonstrate that glycogen is an essential reservoir that is used upon acute hyperosmotic stress to generate glycerol and promote fast and efficient adaptation to prevent water loss and ensure survival. We show that in <italic>flcn-1(ok975)</italic> mutant animals, this phenotype is significantly enhanced, due to the robust AMPK-mediated accumulation of glycogen, which is rapidly converted to the osmolyte glycerol upon salt stress. Our results also suggest that the FLCN/AMPK pathway might be an evolutionarily conserved key regulator of glycogen metabolism and stress resistance.</p></sec><sec sec-type="results" id="sec002"><title>Results</title><sec id="sec003"><title>Loss of <italic>flcn-1</italic> confers resistance to hyperosmotic stress in <italic>C</italic>. <italic>elegans</italic>
</title><p>Since we have previously observed that loss of <italic>flcn-1</italic> in <italic>C</italic>. <italic>elegans</italic> increases AMPK-dependent resistance to energy stresses including oxidative stress, heat, and anoxia [<xref rid="pgen.1005520.ref028" ref-type="bibr">28</xref>], we asked whether it would also increase resistance to hyperosmotic stress. We measured the survival of wt and <italic>flcn-1(ok975)</italic> animals (<xref rid="pgen.1005520.s001" ref-type="supplementary-material">S1A Fig</xref>) on plates supplemented with 400mM and 500mM NaCl. Loss of <italic>flcn-1</italic> conferred a significant increase in resistance to hyperosmotic stress (<xref rid="pgen.1005520.g001" ref-type="fig">Fig 1A and 1B</xref> and <xref rid="pgen.1005520.s007" ref-type="supplementary-material">S1 Table</xref>). Although NaCl treatment severely reduced the survival of both wt and <italic>flcn-1(ok975)</italic> animals as compared to untreated animals (Figs <xref rid="pgen.1005520.g001" ref-type="fig">1A, 1B</xref> and <xref rid="pgen.1005520.s001" ref-type="supplementary-material">S1B</xref>), the mean survival of <italic>flcn-1(ok975)</italic> animals increased by ~2 and ~3 fold upon treatment with 400mM and 500mM NaCl respectively, as compared to wt animals (<xref rid="pgen.1005520.g001" ref-type="fig">Fig 1A&#x02013;1C</xref>). Moreover, we did not observe a significant difference in lifespan between untreated wt and <italic>flcn-1(ok975)</italic> animals, as reported previously [<xref rid="pgen.1005520.ref028" ref-type="bibr">28</xref>] (<xref rid="pgen.1005520.s007" ref-type="supplementary-material">S1B Fig</xref> and <xref rid="pgen.1005520.s007" ref-type="supplementary-material">S1 Table</xref>). Importantly, NaCl treatment led to shrinkage and paralysis in both wt and <italic>flcn-1(ok975)</italic> animals. However, <italic>flcn-1(ok975)</italic> mutant nematodes recover significantly faster than wt animals after 2 hours of NaCl treatment suggesting that the mechanism of adaptation to salt is more robust upon loss <italic>flcn-1</italic> (<xref rid="pgen.1005520.g001" ref-type="fig">Fig 1D</xref>). We also observed a significantly greater number of wt animals with more than 30% reduction of body size as compared to <italic>flcn-1</italic> suggesting that loss of <italic>flcn-1</italic> activates pathways that favor body size recovery after hyperosmotic stress (<xref rid="pgen.1005520.g001" ref-type="fig">Fig 1E</xref>). Importantly, the hyperosmotic stress resistance phenotype can be rescued by transgenic re-expression of <italic>C</italic>. <italic>elegans flcn-1</italic> (<xref rid="pgen.1005520.s007" ref-type="supplementary-material">S1 Table</xref> and Figs <xref rid="pgen.1005520.g001" ref-type="fig">1F</xref> and <xref rid="pgen.1005520.s001" ref-type="supplementary-material">S1A</xref>).</p><fig id="pgen.1005520.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1005520.g001</object-id><label>Fig 1</label><caption><title>Loss of <italic>flcn-1</italic> confers resistance to hyperosmotic stress.</title><p>(A-C, F) Percent survival (A, B, F) and mean survival (C) of indicated worm strains exposed to 400mM and 500mM NaCl. (D) Percent recovery from paralysis of wt and <italic>flcn-1(ok975)</italic> animals after 2 hours from exposure to 400mM NaCl. Data represent mean &#x000b1; SEM, n&#x02265; 3. (E) Representative images of wt and <italic>flcn-1(ok975)</italic> animals treated with 400mM NaCl for 48 hours.</p></caption><graphic xlink:href="pgen.1005520.g001"/></fig><p>In addition, we used Agilent whole genome <italic>C</italic>. <italic>elegans</italic> microarrays to determine transcriptional profile differences between wt and <italic>flcn-1(ok975)</italic> mutant animals [<xref rid="pgen.1005520.ref030" ref-type="bibr">30</xref>]. Key genes that were differentially expressed were validated by qRT-PCR (<xref rid="pgen.1005520.s001" ref-type="supplementary-material">S1C Fig</xref>). We compared our data to published transcriptional profiles and found a significant overlap between genes upregulated in untreated <italic>flcn-1(ok975)</italic> animals versus genes upregulated in wt animals treated with NaCl or osmotic stress resistant strains including <italic>osm-7</italic> and <italic>osm-11</italic> [<xref rid="pgen.1005520.ref008" ref-type="bibr">8</xref>] (<xref rid="pgen.1005520.s001" ref-type="supplementary-material">S1D, S1E and S1F Fig</xref> and <xref rid="pgen.1005520.s008" ref-type="supplementary-material">S2</xref>, <xref rid="pgen.1005520.s009" ref-type="supplementary-material">S3</xref> and <xref rid="pgen.1005520.s010" ref-type="supplementary-material">S4</xref> Tables). Altogether, these data suggest that <italic>flcn-1</italic> is involved in a mechanism of regulating the resistance to hyperosmotic stress.</p></sec><sec id="sec004"><title>Loss of <italic>flcn-1</italic> increases glycogen content, which mediates resistance to hyperosmotic stress</title><p>To determine how loss of <italic>flcn-1</italic> increases resistance to hyperosmotic stress, we assessed the morphological differences between wt and <italic>flcn-1(ok975)</italic> using electron microscopy with or without NaCl treatment. Interestingly, we observed an increase in the size and number of glycogen stores in adult (<xref rid="pgen.1005520.g002" ref-type="fig">Fig 2Ai and 2Aii</xref>) and L4 (<xref rid="pgen.1005520.s002" ref-type="supplementary-material">S2Ai, S2Aii, S2Ci, and S2Cii Fig</xref>) <italic>flcn-1(ok975)</italic> mutant worms as compared to wt. Specifically, our transmission electron data indicate a strong accumulation of glycogen in the hypodermis, muscle, and intestine of <italic>flcn-1(ok975)</italic> animals as compared to wt (<xref rid="pgen.1005520.s002" ref-type="supplementary-material">S2C Fig</xref>). Glycogen has been previously shown to accumulate in these tissues in <italic>C</italic>. <italic>elegans</italic> [<xref rid="pgen.1005520.ref031" ref-type="bibr">31</xref>]. Importantly, glycogen stores were barely detectable in wt and <italic>flcn-1(ok975)</italic> animals after NaCl treatment, suggesting that glycogen degradation is used to protect the animals from hyperosmotic stress (<xref rid="pgen.1005520.g002" ref-type="fig">Fig 2Aiii, 2Aiv</xref>). Furthermore, we found that the prominent accumulation and salt stress-dependent degradation of glycogen in <italic>flcn-1(ok975)</italic> adult animals occurs in the hypodermis (Figs <xref rid="pgen.1005520.g002" ref-type="fig">2A</xref>, <xref rid="pgen.1005520.s002" ref-type="supplementary-material">S2A and S2C</xref>). We validated and quantified the increase in glycogen levels conferred by loss of <italic>flcn-1</italic> using iodine staining which has been previously shown to specifically stain glycogen in <italic>C</italic>. <italic>elegans</italic> [<xref rid="pgen.1005520.ref032" ref-type="bibr">32</xref>&#x02013;<xref rid="pgen.1005520.ref034" ref-type="bibr">34</xref>] (<xref rid="pgen.1005520.g002" ref-type="fig">Fig 2B and 2C</xref>). In accordance with the electron microscopy results, glycogen levels were significantly increased in untreated <italic>flcn-1(ok975)</italic> animals as compared to wt, and NaCl treatment severely reduced glycogen content in both wt and <italic>flcn-1(ok975)</italic> animals (<xref rid="pgen.1005520.g002" ref-type="fig">Fig 2B and 2C</xref>).</p><fig id="pgen.1005520.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1005520.g002</object-id><label>Fig 2</label><caption><title>Loss of <italic>flcn-1</italic> increases glycogen content, which mediates resistance to hyperosmotic stress.</title><p>(A) Representative electron micrographs from longitudinal sections of the hypodermis in indicated nematodes strains exposed or not to 400mM NaCl for 16 hours. Arrows represent glycogen stores. Scale bars: 2&#x003bc;m. (B, C) Iodine staining (B) and quantification of staining intensities (C) of indicated worm strains treated or not with 400mM NaCl for 16 hours. Data represent mean &#x000b1; SEM, n&#x02265; 3. (D, E) Percent survival to 400mM NaCl of indicated worm strains treated with indicated RNAi. (F) Relative mRNA levels of indicated target genes in indicated strains with or without 400mM NaCl treatment for 2 hours. Data represent the mean &#x000b1; SEM, n&#x02265; 3.</p></caption><graphic xlink:href="pgen.1005520.g002"/></fig><p>We then asked whether glycogen is used to protect wt and <italic>flcn-1(ok975)</italic> animals from damage during hyperosmotic stress. Glycogen synthase (<italic>gsy-1)</italic> is responsible for the synthesis of glycogen from UDP-glucose molecules and glycogen phosphorylase (<italic>pygl-1)</italic> catalyzes glycogen breakdown to form glucose-1-phosphate [<xref rid="pgen.1005520.ref035" ref-type="bibr">35</xref>]. Importantly, the inhibition of glycogen synthesis or degradation using RNAi against <italic>gsy-1</italic> and <italic>pygl-1</italic> respectively, strongly reduced the survival in both wt and <italic>flcn-1(ok975)</italic> animals to an equal level, suggesting that the accumulation of glycogen and its degradation are both required for the resistance of wt and <italic>flcn-1(ok975)</italic> mutant animals to hyperosmotic stress (<xref rid="pgen.1005520.g002" ref-type="fig">Fig 2D and 2E</xref> and <xref rid="pgen.1005520.s007" ref-type="supplementary-material">S1 Table</xref>).</p><p>Additionally, transcript levels of <italic>gsy-1</italic> and <italic>pygl-1</italic> with or without 2 hours of 400mM NaCl stress remained unchanged suggesting allosteric regulation of glycogen metabolism (<xref rid="pgen.1005520.g002" ref-type="fig">Fig 2F</xref>). Altogether, these results demonstrate that the accumulation of glycogen stores and the degradation of glycogen are essential to survive hyperosmotic stress in wt and <italic>flcn-1(ok975)</italic> mutant animals.</p></sec><sec id="sec005"><title>Hyperosmotic stress resistance of <italic>flcn-1(ok975)</italic> animals is dependent on AMPK</title><p>Since we have previously reported that the <italic>flcn-1</italic>-dependent resistance to energy stresses requires <italic>aak-2</italic>, the worm ortholog of the AMPK&#x003b1; subunit, we wondered whether the hyperosmotic stress resistance phenotype conferred by loss of <italic>flcn-1</italic> is also mediated by AMPK [<xref rid="pgen.1005520.ref028" ref-type="bibr">28</xref>]. AMPK is activated by hyperosmotic stress in mammalian systems [<xref rid="pgen.1005520.ref036" ref-type="bibr">36</xref>] and its deletion confers sensitivity to NaCl stress in yeast [<xref rid="pgen.1005520.ref037" ref-type="bibr">37</xref>]. <italic>C</italic>. <italic>elegans</italic> nematodes have two catalytic &#x003b1; subunits <italic>aak-1</italic> and <italic>aak-2</italic>. Loss of <italic>aak-2</italic> was shown to mediate lifespan extension and resistance to various stresses including oxidative stress, anoxia, nutrient deprivation, and dietary restriction [<xref rid="pgen.1005520.ref038" ref-type="bibr">38</xref>&#x02013;<xref rid="pgen.1005520.ref042" ref-type="bibr">42</xref>]. To determine whether AMPK is involved in the increased resistance of <italic>flcn-1(ok975)</italic> animals to stress, we crossed <italic>aak-2(ok524 and gt33)</italic> [<xref rid="pgen.1005520.ref039" ref-type="bibr">39</xref>,<xref rid="pgen.1005520.ref043" ref-type="bibr">43</xref>] and <italic>aak-1(tm1944)</italic> [<xref rid="pgen.1005520.ref043" ref-type="bibr">43</xref>] loss of function mutants with <italic>flcn-1(ok975)</italic> animals. Interestingly, loss of <italic>aak-2(ok524</italic> and <italic>gt33)</italic> or <italic>aak-1(tm1044)</italic> alone conferred stress sensitivity but did not fully suppress the increased survival to hyperosmotic stress conferred by loss of <italic>flcn-1</italic> (<xref rid="pgen.1005520.g003" ref-type="fig">Fig 3A, 3B and 3C</xref> and <xref rid="pgen.1005520.s007" ref-type="supplementary-material">S1 Table</xref>). To control for compensatory effects, we generated the <italic>flcn-1(ok975); aak-1(tm1944); aak-2(ok524)</italic> triple mutant and compared its survival under high salt conditions to <italic>aak-1(tm1944); aak-2(ok524)</italic> double mutant animals. Simultaneous loss of <italic>aak-1</italic> and <italic>aak-2</italic> completely abolished the increased osmotic stress resistance upon loss <italic>flcn-1</italic> demonstrating that this phenotype requires both AMPK catalytic subunits (<xref rid="pgen.1005520.g003" ref-type="fig">Fig 3D</xref> and <xref rid="pgen.1005520.s007" ref-type="supplementary-material">S1 Table</xref>).</p><fig id="pgen.1005520.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1005520.g003</object-id><label>Fig 3</label><caption><title>The increased survival to hyperosmotic stress and the accumulation of glycogen in <italic>flcn-1</italic> mutant worms require AMPK.</title><p>(A-D) Percent survival of indicated worm strains exposed to 400mM NaCl. (A) <italic>aak-2(ok524)</italic>, (B) <italic>aak-2(gt33)</italic>, (C) <italic>aak-1(tm1944)</italic>, (D) <italic>aak-1(tm1944)</italic>; <italic>aak-2(ok524)</italic>. (E, F) Iodine staining (E) and quantification of staining intensities (F) of indicated worm strains. Scale bar:100&#x003bc;m. Data represent the mean &#x000b1; SEM of at least 3 independent experiments.</p></caption><graphic xlink:href="pgen.1005520.g003"/></fig></sec><sec id="sec006"><title>The accumulation of glycogen in <italic>flcn-1</italic> mutant worms depends on AMPK</title><p>AMPK has been shown to regulate glycogen metabolism in different organisms [<xref rid="pgen.1005520.ref044" ref-type="bibr">44</xref>&#x02013;<xref rid="pgen.1005520.ref056" ref-type="bibr">56</xref>]. In fact, acute activation of AMPK leads to glycogen degradation [<xref rid="pgen.1005520.ref044" ref-type="bibr">44</xref>&#x02013;<xref rid="pgen.1005520.ref047" ref-type="bibr">47</xref>], while chronic AMPK activation results in glycogen accumulation [<xref rid="pgen.1005520.ref048" ref-type="bibr">48</xref>&#x02013;<xref rid="pgen.1005520.ref050" ref-type="bibr">50</xref>]. Since we observed an increased constitutive phosphorylation of AMPK upon loss of <italic>flcn-1</italic> in nematodes and mammalian cells [<xref rid="pgen.1005520.ref028" ref-type="bibr">28</xref>,<xref rid="pgen.1005520.ref029" ref-type="bibr">29</xref>], we hypothesized that the chronic AMPK activation in <italic>flcn-1(ok975)</italic> mutants may lead to increased glycogen levels. We determined glycogen levels in <italic>aak-1(tm1944); aak-2(ok524)</italic> animals compared to <italic>flcn-1(ok975); aak-1(tm1944); aak-2(ok524)</italic> triple mutant worms and found that loss of AMPK strongly reduced glycogen levels in both strains (<xref rid="pgen.1005520.g003" ref-type="fig">Fig 3E and 3F</xref>). This suggests that the chronic AMPK activation in <italic>flcn-1</italic> animals is leading to glycogen accumulation. Interestingly, the survival and glycogen accumulation in <italic>aak-1(tm1944); aak-2(ok524)</italic> mutant animals was also severely reduced as compared to wt (<xref rid="pgen.1005520.g003" ref-type="fig">Fig 3E and 3F</xref>), suggesting an important role for AMPK in maintaining glycogen stores, which are used for hyperosmotic stress resistance.</p></sec><sec id="sec007"><title>Autophagy is not fully required for the hyperosmotic stress resistance conferred by loss of <italic>flcn-1</italic>
</title><p>Autophagy is a biological survival process through which cellular components and damaged organelles are degraded to produce energy upon starvation [<xref rid="pgen.1005520.ref057" ref-type="bibr">57</xref>]. We reported previously that autophagy was essential for the energy stress resistance of <italic>flcn-1(ok975)</italic> mutant animals [<xref rid="pgen.1005520.ref028" ref-type="bibr">28</xref>]. Therefore, we asked whether autophagy plays a role in osmotic stress resistance. Interestingly, <italic>atg-18(gk378)</italic> mutant animals were hypersensitive to high salt concentrations suggesting that autophagy is a process involved in the resistance to hyperosmotic stress. However, loss of <italic>flcn-1</italic> significantly increased the resistance of <italic>atg-18(gk378)</italic> animals suggesting that <italic>flcn-1</italic>-dependent hyperosmotic stress resistance does not require autophagy, which is different from what we observed before during energy stress [<xref rid="pgen.1005520.ref028" ref-type="bibr">28</xref>] (<xref rid="pgen.1005520.s003" ref-type="supplementary-material">S3 Fig</xref> and <xref rid="pgen.1005520.s007" ref-type="supplementary-material">S1 Table</xref>).</p></sec><sec id="sec008"><title>Glycogen degradation leads to heightened glycerol levels and protects animals from hyperosmotic stress</title><p>Degradation of glycogen polymers leads to the formation of glucose-1-phosphate which is converted to glucose-6-phosphate, an important metabolite used in multiple pathways including glycolysis, pentose phosphate pathway, and glycerol production (<xref rid="pgen.1005520.g004" ref-type="fig">Fig 4A</xref>) [<xref rid="pgen.1005520.ref035" ref-type="bibr">35</xref>]. We hypothesized that glycogen degradation may lead to heightened glycerol levels that could protect the animals from hyperosmotic stress. To address this, we measured the mRNA levels of <italic>gpdh-1</italic> and <italic>gpdh-2</italic>. Interestingly, we observed a significant 2-fold increase in <italic>gpdh-1</italic> but not <italic>gpdh-2</italic> at unstressed conditions in <italic>flcn-1(ok975)</italic> mutant animals compared to wt, which was consistent with our microarray results (<xref rid="pgen.1005520.g004" ref-type="fig">Fig 4B and 4C</xref> and <xref rid="pgen.1005520.s008" ref-type="supplementary-material">S2 Table</xref>). Strikingly, after 2 hour treatment with 400mM NaCl, we detected a strong induction of <italic>gpdh-1</italic> and <italic>gpdh-2</italic> mRNA levels in wt and <italic>flcn-1(ok975)</italic> mutant animals, which was significantly enhanced in the latter (<xref rid="pgen.1005520.g004" ref-type="fig">Fig 4B and 4C</xref>). Accordingly, <italic>flcn-1(ok975)</italic> mutant animals exhibit higher glycerol content at basal level as compared to wt animals which was further increased upon NaCl treatment (<xref rid="pgen.1005520.g004" ref-type="fig">Fig 4D</xref>).</p><fig id="pgen.1005520.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1005520.g004</object-id><label>Fig 4</label><caption><title>Glycogen degradation heightens glycerol levels and protects animals from hyperosmotic stress.</title><p>(A) Representative scheme of glycogen metabolism and osmolyte production in worms. (B-D) Relative mRNA levels of <italic>gpdh-1</italic> and <italic>gpdh-2</italic> (B, C) and glycerol content (D) in wt and <italic>flcn-1(ok975)</italic> L4/young adult animals treated with or without 400mM NaCl for 2 hours. Data represent mean &#x000b1; SEM, n &#x02265;3. (E) Percent survival of indicated worm strains exposed to 400mM NaCl.</p></caption><graphic xlink:href="pgen.1005520.g004"/></fig><p>To determine the importance of glycerol in the protection against hyperosmotic stress, we inhibited <italic>gpdh-1</italic> and <italic>gpdh-2</italic> using RNAi and using mutant strains. Importantly, treatment of <italic>flcn</italic>-<italic>1(ok975)</italic> animals with RNAi against either <italic>gpdh-1</italic> or <italic>gpdh-2</italic> alone did not fully suppress the increased resistance of <italic>flcn-1(ok975)</italic> animals to hyperosmotic stress (<xref rid="pgen.1005520.s004" ref-type="supplementary-material">S4A and S4B Fig</xref>). We then compared the resistance of <italic>flcn-1(ok975); gpdh-1(kb24); gpdh-2(kb33)</italic> triple mutant animals to <italic>gpdh-1(kb24); gpdh-2(kb33)</italic> mutant nematodes. Simultaneous loss of <italic>gpdh-1</italic> and <italic>gpdh-2</italic> strongly reduced the survival of <italic>flcn-1(ok975)</italic> mutant animals demonstrating an important role for the osmolyte glycerol in the survival of <italic>flcn-1(ok975)</italic> and wt animals (<xref rid="pgen.1005520.g004" ref-type="fig">Fig 4E</xref> and <xref rid="pgen.1005520.s007" ref-type="supplementary-material">S1 Table</xref>). Altogether, these data suggest that upon hyperosmotic stress glycogen stores are metabolized into the osmolyte glycerol via enhanced transcriptional upregulation of <italic>gpdh</italic> enzymes. This glycerol mediated osmo-protective phenotype is significantly enhanced upon loss of <italic>flcn-1</italic> in nematodes.</p></sec><sec id="sec009"><title>Loss of <italic>pmk-1</italic> does not fully suppress the hyperosmotic stress resistance conferred by loss of <italic>flcn-1</italic>
</title><p>HOG/p38/PMK-1 MAP kinase signaling is widely known to control adaptation to hypertonic stresses in multiple organisms [<xref rid="pgen.1005520.ref004" ref-type="bibr">4</xref>,<xref rid="pgen.1005520.ref009" ref-type="bibr">9</xref>,<xref rid="pgen.1005520.ref058" ref-type="bibr">58</xref>]. As expected, <italic>pmk-1(km25)</italic> mutant worms were highly sensitive to osmotic stress. However, loss of <italic>pmk-1</italic> in <italic>flcn-1(ok975)</italic> mutant animals reduced but did not fully suppress the increased resistance conferred by <italic>flcn-1</italic> depletion (<xref rid="pgen.1005520.s011" ref-type="supplementary-material">S5A Fig</xref> and <xref rid="pgen.1005520.s007" ref-type="supplementary-material">S1 Table</xref>). Supporting this result, the expression of <italic>gpdh-1</italic> is ~2-fold higher in <italic>flcn-1(ok975); pmk-1(km25)</italic> mutant animals as compared to <italic>pmk-1(km25)</italic> alone (<xref rid="pgen.1005520.s005" ref-type="supplementary-material">S5B Fig</xref>). Altogether, this suggests that <italic>pmk-1</italic> is not involved in the transcriptional upregulation of <italic>gpdh-1</italic> upon loss of <italic>flcn-1</italic> and that it acts in parallel to <italic>flcn-1</italic> and <italic>aak-1/2</italic>.</p></sec><sec id="sec010"><title>The increased accumulation of glycogen content conferred by loss of FLCN is conserved from <italic>C</italic>. <italic>elegans</italic> to humans</title><p>Glycogen is linked to the progression and the aggressiveness of multiple cancer types in humans [<xref rid="pgen.1005520.ref059" ref-type="bibr">59</xref>,<xref rid="pgen.1005520.ref060" ref-type="bibr">60</xref>]. To determine whether loss of FLCN also leads to the accumulation of glycogen in mammalian systems, we used the <italic>Flcn</italic>
<sup><italic>flox/flox</italic></sup>/<italic>Pax8-Cre</italic> mouse model where <italic>Flcn</italic> is specifically deleted in the kidney and determined glycogen content using Periodic-Acid-Schiff (PAS) staining. The <italic>Flcn</italic>
<sup><italic>flox/flox</italic></sup>/<italic>Pax8-Cre</italic> mouse was generated by mating <italic>Pax8-Cre</italic> mice with the <italic>Flcn</italic>
<sup><italic>flox/flox</italic></sup> C57BL/6 mice. By six months of age, all mice developed visible macroscopic lesions confirmed as cysts that later developed into tumors. Strikingly, kidneys from <italic>Flcn</italic>
<sup><italic>flox/flox</italic></sup>/<italic>Pax8-Cre</italic> mice accumulated higher glycogen levels as compared to normal kidneys from <italic>Flcn</italic>
<sup><italic>flox/flox</italic></sup> mouse littermates (Figs <xref rid="pgen.1005520.g005" ref-type="fig">5A</xref> and <xref rid="pgen.1005520.s006" ref-type="supplementary-material">S6A</xref>). Our data show a stronger glycogen accumulation in the kidney cortex, which is due to the fact that <italic>Pax8</italic> is expressed in the epithelial cells of the proximal and distal renal tubules, loops of Henle, collecting ducts and the parietal epithelial cells of Bowman&#x02019;s capsule [<xref rid="pgen.1005520.ref061" ref-type="bibr">61</xref>]. Importantly, PAS staining of tumors from BHD patients also indicate a strong accumulation of glycogen as compared to adjacent unaffected kidneys (Figs <xref rid="pgen.1005520.g005" ref-type="fig">5B</xref> and <xref rid="pgen.1005520.s006" ref-type="supplementary-material">S6B</xref>). We also compared the expression level of glycogen biosynthesis and degradation genes in 3 different subtypes of kidney cancer, kidney renal papillary cell carcinoma (KIRP), kidney renal clear cell carcinoma (KIRC), and kidney chromophobe (KICH) tumors. Strikingly, we observed a significant upregulation of genes involved in the synthesis and degradation of glycogen (<xref rid="pgen.1005520.g005" ref-type="fig">Fig 5C</xref> and <xref rid="pgen.1005520.s011" ref-type="supplementary-material">S5 Table</xref>). We also observed that the expression of 46% of these genes are negatively correlated with FLCN expression (<xref rid="pgen.1005520.g005" ref-type="fig">Fig 5D</xref>). Overall, our data indicate that the accumulation of glycogen upon loss of FLCN is be conserved from nematodes to mammals, and that it might play a role in tumorigenesis.</p><fig id="pgen.1005520.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1005520.g005</object-id><label>Fig 5</label><caption><title>The FLCN-dependent glycogen accumulation is conserved from <italic>C</italic>. <italic>elegans</italic> to humans.</title><p>(A-B) PAS staining of kidney sections from wt and <italic>Flcn</italic> kidney-specific KO mice (A) and human BHD kidney tumor in comparison with an adjacent region from the same individual (B). Scale bars:100&#x003bc;m. (C) Table indicating the upregulated glycogen metabolism genes in kidney tumors (KIRC, KIRP, and KICH) as compared to normal kidney. The sign (+) indicates genes that are upregulated in these tumors. The values are indicated in <xref rid="pgen.1005520.s011" ref-type="supplementary-material">S5 Table</xref>. (D) Heat map indicating correlation of expression between glycogen metabolism genes and <italic>FLCN</italic> in KIRC, KIRP, and KICH tumors. Green and red colors indicate genes that are negatively or positively correlated with FLCN expression, respectively.</p></caption><graphic xlink:href="pgen.1005520.g005"/></fig></sec></sec><sec sec-type="conclusions" id="sec011"><title>Discussion</title><p>A common mechanism to survive osmotic stress is the synthesis of compatible osmolytes [<xref rid="pgen.1005520.ref003" ref-type="bibr">3</xref>]. In yeast and in <italic>C</italic>. <italic>elegans</italic>, the rapid accumulation of glycerol after hyperosmotic stress has been demonstrated [<xref rid="pgen.1005520.ref004" ref-type="bibr">4</xref>,<xref rid="pgen.1005520.ref005" ref-type="bibr">5</xref>]. However, it is not clear what fuels glycerol production upon acute hyperosmotic stress. Here we show that animals have evolved an interesting strategy to maintain glycogen stores, which can serve as fuel for glycerol production to ensure survival to acute hyperosmotic stress (<xref rid="pgen.1005520.g006" ref-type="fig">Fig 6</xref>). While storage of soluble glucose molecules in cells would lead to osmotic stress, the storage of glucose in the form of insoluble glycogen polymers ensures osmotic homeostasis. Importantly, our data uncover that glycogen stores have a dual role: they can serve as a reservoir for production of energy or osmolytes. Indeed, pretreatment of wt and <italic>flcn-1(ok975)</italic> animals with oxidative and energy stressor paraquat, depletes glycogen stores rapidly and suppresses survival upon treatment with 400mM NaCl (<xref rid="pgen.1005520.s002" ref-type="supplementary-material">S2A and S2B Fig</xref>).</p><fig id="pgen.1005520.g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1005520.g006</object-id><label>Fig 6</label><caption><title>Graphical representation of FLCN-1/AMPK hyperosmotic stress resistance pathway.</title><p>Loss of <italic>flcn-1</italic> chronically activates AMPK and leads to glycogen accumulation under normal conditions. Upon exposure to hyperosmotic stress, glycogen is rapidly degraded leading to the production of glycerol and animal survival.</p></caption><graphic xlink:href="pgen.1005520.g006"/></fig><p>The regulation of glycogen metabolism by AMPK has long been a paradox [<xref rid="pgen.1005520.ref044" ref-type="bibr">44</xref>&#x02013;<xref rid="pgen.1005520.ref050" ref-type="bibr">50</xref>]. Acute activation of AMPK, by in vitro short term treatment of the AMP mimetic drug 5-Aminoimidazole-4-Carboxamide Riboside (AICAR), leads to the phosphorylation and inhibition of glycogen synthase, which favors glycogen degradation for supply of short term energy [<xref rid="pgen.1005520.ref044" ref-type="bibr">44</xref>&#x02013;<xref rid="pgen.1005520.ref047" ref-type="bibr">47</xref>]. However, chronic AMPK activation induced by a long term AICAR treatment or by genetic manipulation of AMPK regulatory subunits, results in glycogen accumulation via glucose-6-phosphate-dependent allosteric activation of glycogen synthase, which bypasses the inhibitory effect of the AMPK-mediated phosphorylation [<xref rid="pgen.1005520.ref048" ref-type="bibr">48</xref>&#x02013;<xref rid="pgen.1005520.ref050" ref-type="bibr">50</xref>]. In agreement, constitutive AMPK activation through transgenic expression of activating mutations in the &#x003b3;2 and &#x003b3;3 subunits in mice and pigs leads to substantial glycogen accumulation in cardiac and skeletal muscles [<xref rid="pgen.1005520.ref036" ref-type="bibr">36</xref>,<xref rid="pgen.1005520.ref050" ref-type="bibr">50</xref>&#x02013;<xref rid="pgen.1005520.ref053" ref-type="bibr">53</xref>,<xref rid="pgen.1005520.ref055" ref-type="bibr">55</xref>,<xref rid="pgen.1005520.ref056" ref-type="bibr">56</xref>]. In light of these results, our data indicate that chronic AMPK activation upon loss of <italic>flcn-1</italic> leads to glycogen accumulation. Similarly to what has been shown in yeast [<xref rid="pgen.1005520.ref054" ref-type="bibr">54</xref>], we demonstrate that AMPK-deficient strains exhibit reduced glycogen content as compared to wt. We further show that the accumulation of glycogen in wt and <italic>flcn-1(ok975)</italic> mutant animals depends on AMPK. Based on the data presented here together with our recently published reports [<xref rid="pgen.1005520.ref028" ref-type="bibr">28</xref>,<xref rid="pgen.1005520.ref029" ref-type="bibr">29</xref>], we propose that FLCN is a key regulatory component of AMPK.</p><p>
<italic>Flcn</italic> muscle-specific knockout mice and <italic>Fnip1</italic> knockout mice exhibited increased glycogen accumulation in muscles and liver, respectively [<xref rid="pgen.1005520.ref062" ref-type="bibr">62</xref>,<xref rid="pgen.1005520.ref063" ref-type="bibr">63</xref>]. Here we show that loss of FLCN leads to glycogen accumulation in kidneys of mice and in the tumors of BHD patients, suggesting that this pathway is evolutionarily conserved. In agreement with the important role for glycogen in organismal survival to stress, glycogen can be used by tumor cells to survive harsh microenvironments such as hypoxia [<xref rid="pgen.1005520.ref059" ref-type="bibr">59</xref>,<xref rid="pgen.1005520.ref064" ref-type="bibr">64</xref>]. In fact, glycogen accumulates in many cancer types [<xref rid="pgen.1005520.ref064" ref-type="bibr">64</xref>] and inhibition of its degradation led to induction of apoptosis and impaired <italic>in vivo</italic> growth of tumor xenografts [<xref rid="pgen.1005520.ref059" ref-type="bibr">59</xref>].</p><p>Importantly, our data might impinge on a novel role for glycogen in tumorigenesis. In addition to its critical role as an energy supplier, we speculate that glycogen degradation might lead to higher osmolyte levels to help survive hyperosmotic tumor microenvironments. In fact, we found that taurine and sorbitol synthesis genes, CSAD and AKR1B1 respectively, are upregulated in many kidney tumors (<xref rid="pgen.1005520.s011" ref-type="supplementary-material">S5 Table</xref>). Supporting this idea, recent evidence shed light on an important role of the nuclear factor of activated T cells 5 (NFAT5), a major transcription factor that regulates osmotic stress resistance genes, in promoting tumorigenesis and metastasis of several cancer types [<xref rid="pgen.1005520.ref002" ref-type="bibr">2</xref>,<xref rid="pgen.1005520.ref065" ref-type="bibr">65</xref>&#x02013;<xref rid="pgen.1005520.ref067" ref-type="bibr">67</xref>]. In summary, we speculate that the increased glycogen stores in tumors might lead to extended survival of cells under hyperosmotic stress, which could ultimately lead to neoplastic transformation by accumulation of DNA damage [<xref rid="pgen.1005520.ref001" ref-type="bibr">1</xref>, <xref rid="pgen.1005520.ref002" ref-type="bibr">2</xref>].</p></sec><sec sec-type="materials|methods" id="sec012"><title>Materials and Methods</title><sec id="sec013"><title>
<italic>C</italic>. <italic>elegans</italic> strains, maintenance, and RNAi treatments</title><p>
<italic>C</italic>. <italic>elegans</italic> strains were obtained from the <italic>Caenorhabditis</italic> Genetics Center (<xref rid="pgen.1005520.s012" ref-type="supplementary-material">S6 Table</xref>). Nematodes were maintained and synchronized using standard culture methods [<xref rid="pgen.1005520.ref068" ref-type="bibr">68</xref>]. The RNAi feeding experiments were performed as described in [<xref rid="pgen.1005520.ref069" ref-type="bibr">69</xref>], and bacteria transformed with empty vector were used as control. For all RNAi experiments, phenotypes were scored with the F1 generation.</p></sec><sec id="sec014"><title>Osmotic stress resistance assay</title><p>To measure osmotic stress resistance, synchronized 1 day adult worms were transferred to high concentration NaCl plates. Survival was measured daily. Worms that responded by movement to touch with the platinum wire were considered as alive.</p></sec><sec id="sec015"><title>Percent recovery assay</title><p>To measure the percentage of animals that recovered after hyperosmotic shock, 1 day adult animals were transferred to high NaCl plates. Animals shrink and paralyse shortly after exposure to NaCl. After 2 hours, animals that were able to move their entire body forward or backward in response to touch with a platinum wire were considered as &#x0201c;recovered&#x0201d;. Paralyzed animals often look straight and are unable to move.</p></sec><sec id="sec016"><title>RNA extraction and real-time PCR</title><p>Synchronized young adult nematodes were harvested and total RNA was extracted with Trizol. Reverse transcription and qRT-PCRs were performed as previously described [<xref rid="pgen.1005520.ref028" ref-type="bibr">28</xref>]. Transcripts were normalized to <italic>cdc-42</italic>.</p></sec><sec id="sec017"><title>Microarray experiment and gene overlap analysis</title><p>Synchronized young adult wt and <italic>flcn-1(ok975)</italic> animals were harvested and RNA was extracted using Trizol and purified using Qiagen RNeasy columns. Total RNA samples were then hybridized onto Agilent gene chips. Fold change values are calculated using the mean of both data sets. The overlapping genes between <italic>flcn-1(ok975)</italic> mutant animals and the specified conditions and strains [<xref rid="pgen.1005520.ref008" ref-type="bibr">8</xref>] were performed using the &#x0201c;compare two lists&#x0201d; online tool at <ext-link ext-link-type="uri" xlink:href="http://www.nemates.org/MA/progs/Compare.html">http://www.nemates.org/MA/progs/Compare.html</ext-link>. The significance of the overlap and enrichment scores were determined via hypergeometric distribution method using <ext-link ext-link-type="uri" xlink:href="http://nemates.org/MA/progs/overlap_stats.html">http://nemates.org/MA/progs/overlap_stats.html</ext-link>. The number of genes in the <italic>C</italic>. <italic>elegans</italic> genome was considered to be19,735.</p></sec><sec id="sec018"><title>Transmission electron microscopy</title><p>Synchronized 1 day adult nematodes were transferred to 400mM NaCl plates for 16 hours. Recovering animals were picked and transferred for TEM. Immersion fixation and embedding was performed according to [<xref rid="pgen.1005520.ref070" ref-type="bibr">70</xref>]. Thin sections were cut on an RMC Powertome XL (Boeckler Instruments) using a diamond knife (DDK) and collected on Pioloform-coated copper slot grids. Grids were post-stained with 4% uranyl acetate and lead citrate and viewed using a Philips CM10 electron microscope (FEI) equipped with a Morada digital camera (Olympus) and iTEM software (Olympus SIS).</p></sec><sec id="sec019"><title>Glycogen quantification in <italic>C</italic>. <italic>elegans</italic>
</title><p>Synchronized young adult animals were transferred to agarose pads. For comparisons between strains, different conditions were transferred to the same agarose pad and were exposed to iodine vapor for 30 seconds. Animals were rapidly imaged individually. Quantification of the intensity of the staining was performed using ImageJ software.</p></sec><sec id="sec020"><title>Periodic acid Schiff staining</title><p>For human normal kidney and BHD tumor samples, slides were rehydrated after deparaffination and treated with 1% periodic acid for 10 minutes. Periodic acid was washed off with H<sub>2</sub>O and slides were then incubated in Schiff reagent for 20 min. Slides were then rinsed with H<sub>2</sub>O, counterstained with hematoxylin and embedded in entellan. Images were taken as described in [<xref rid="pgen.1005520.ref071" ref-type="bibr">71</xref>].</p></sec><sec id="sec021"><title>Glycerol determination in <italic>C</italic>. <italic>elegans</italic>
</title><p>Synchronized L4/young adult animals exposed or not to 400mM NaCl for 2 hours and were harvested and washed with M9 buffer adjusted to match plate salinity. Pellets were flash frozen in liquid nitrogen. Extraction was performed according to [<xref rid="pgen.1005520.ref005" ref-type="bibr">5</xref>]. Briefly, frozen pellets were ground using a cold mortar and pestle on dry ice. The worm powder was then resuspended in 1N perchloric acid, and solutions were transferred to 15ml conical tubes and kept on ice for 1 hour. The lysate was then centrifuged and the supernatant was neutralized with 5N KOH containing 61.5mM K<sub>2</sub>HPO<sub>4</sub> and 38.5mM KH<sub>2</sub>PO<sub>4</sub>. Glycerol levels were determined using a glycerol determination kit (R-Biopharm, Marshall, MI). Pellets were solubilized in 0.1N NaOH and protein content was determined using BCA. Glycerol levels were normalized to protein content.</p></sec><sec id="sec022"><title>Gene expression analysis in kidney cancers from patients</title><p>TCGA data including 91 kidney chromophobe gene expression RNASeq (IlluminaHiSeq), 604 kidney renal clear cell carcinoma gene expression RNASeq (IlluminaHiSeq), and 258 kidney renal papillary cell carcinoma gene expression RNASeq (IlluminaHiSeq), were extracted from cancer Genomics Browser (<ext-link ext-link-type="uri" xlink:href="https://genome-cancer.ucsc.edu/proj/site/hgHeatmap">https://genome-cancer.ucsc.edu/proj/site/hgHeatmap</ext-link>). For expression analysis, data were expressed as median fold change and the Mann-Whitney test was used to calculate the p-values between normal and tumor samples. P-values less than 0.05 were considered to be statistically significant. For correlation analysis TCGA expression data (same as expression analysis) were used to calculate the Pearson correlation coefficient, and generate a heat map, using R software 3.1.1 (<ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/">http://www.r-project.org/</ext-link>). P-values less than 0.05 were considered to be statistically significant.</p></sec><sec id="sec023"><title>Statistical analyses</title><p>Data are expressed as means &#x000b1;SEM. Statistical analyses for all data were performed by student's t-test, using Excel (Microsoft, Albuquerque, NM, USA). For hyperosmotic stress survival curve comparisons we used the Log-rank Mantel Cox test using GraphPad software. Statistical significance is indicated in figures (* <italic>P&#x0003c;</italic>0.05, **<italic>P</italic>&#x0003c;0.01, ***<italic>P</italic>&#x0003c;0.001) or included in the supplemental tables.</p></sec></sec><sec sec-type="supplementary-material" id="sec024"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pgen.1005520.s001"><label>S1 Fig</label><caption><title>Transcriptional profile of <italic>flcn-1</italic> prior to stress overlap with profiles of wt animals exposed to NaCl and to osmotic stress resistant mutants.</title><p>(A) Western blot showing the expression of FLCN-1 in indicated strains. (B) Lifespan of wt and <italic>flcn-1(ok975)</italic> animals at 20&#x000b0;C. (C) Relative mRNA levels of indicated target genes in wt and <italic>flcn-1(ok975)</italic> animals. (D-F) Ven diagrams showing the overlap of genes in indicated strains and treatments.</p><p>(EPS)</p></caption><media xlink:href="pgen.1005520.s001.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005520.s002"><label>S2 Fig</label><caption><title>Pretreatment of wt and <italic>flcn-1(ok95)</italic> animals with paraquat suppresses hyperosmotic stress resistance.</title><p>(A) Electron micrographs showing glycogen stores in wt and <italic>flcn-1(ok975)</italic> L4/young adult animals with or without 50mM paraquat treatment for 2 hours. Scale bars: 0.5 &#x003bc;m. (B) Percent survival of indicated worm strains pretreated with 70mM PQ for 5 hours followed by exposure to 400mM NaCl. (C) Electron micrographs showing glycogen stores in cross sections from wt and <italic>flcn-1(ok975)</italic> L4/young adult animals (i, ii), and in the head region of a <italic>flcn-1(ok975)</italic> adult animal (iii). H: hypodermis. M: muscle. I: intestine. Scale bars: 5 &#x003bc;m (i, ii) and 2 &#x003bc;m (iii). Arrows indicate glycogen stores.</p><p>(EPS)</p></caption><media xlink:href="pgen.1005520.s002.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005520.s003"><label>S3 Fig</label><caption><title>The increased resistance of <italic>flcn-1(ok975)</italic> animals to NaCl does not fully require autophagy.</title><p>Percent survival of indicated worm strains exposed to 400mM NaCl.</p><p>(EPS)</p></caption><media xlink:href="pgen.1005520.s003.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005520.s004"><label>S4 Fig</label><caption><title>GPDH-1 is critical for the survival of <italic>flcn-1(ok975)</italic> animals to hyperosmotic stress.</title><p>(A-B) Percent survival of wt and <italic>flcn-1(ok975)</italic> mutant animals treated with indicated RNAi.</p><p>(EPS)</p></caption><media xlink:href="pgen.1005520.s004.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005520.s005"><label>S5 Fig</label><caption><title>Involvement of PMK-1 in the transcriptional response of <italic>gpdh-1</italic> and response to hyperosmotic stress.</title><p>(A) Percent survival of indicated worm strains exposed to 400mM NaCl, <italic>pmk-1(km25)</italic>. (B) Relative mRNA levels of <italic>gpdh-1</italic> in indicated worm strains.</p><p>(EPS)</p></caption><media xlink:href="pgen.1005520.s005.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005520.s006"><label>S6 Fig</label><caption><title>The FLCN-dependent glycogen accumulation is conserved from <italic>C</italic>. <italic>elegans</italic> to mammals.</title><p>(A-B) Microscopy images showing PAS and H&#x00026;E staining of kidney sections from wt and <italic>Flcn</italic> kidney-specific KO mice (A) and a human BHD tumor (B). Four individual images were merged in panel B. Scale bars: 200&#x003bc;m.</p><p>(EPS)</p></caption><media xlink:href="pgen.1005520.s006.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005520.s007"><label>S1 Table</label><caption><title>Mean survival on NaCl plates: results and statistical analysis.</title><p>(DOCX)</p></caption><media xlink:href="pgen.1005520.s007.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005520.s008"><label>S2 Table</label><caption><title>Overlapping genes upregulated in <italic>flcn-1(ok975)</italic> animals at basal level and wild-type animals treated with NaCl.</title><p>(DOCX)</p></caption><media xlink:href="pgen.1005520.s008.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005520.s009"><label>S3 Table</label><caption><title>Overlapping genes upregulated in <italic>flcn-1(ok975)</italic> animals and <italic>osm-7(n1515)</italic> animals.</title><p>(DOCX)</p></caption><media xlink:href="pgen.1005520.s009.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005520.s010"><label>S4 Table</label><caption><title>Overlapping genes upregulated in <italic>flcn-1(ok975)</italic> animals and <italic>osm-11(n1604)</italic> animals.</title><p>(DOCX)</p></caption><media xlink:href="pgen.1005520.s010.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005520.s011"><label>S5 Table</label><caption><title>Glycogen metabolism gene regulation in KIRC, KIRP and KICH kidney tumors.</title><p>(DOCX)</p></caption><media xlink:href="pgen.1005520.s011.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005520.s012"><label>S6 Table</label><caption><title>Strains list.</title><p>(DOCX)</p></caption><media xlink:href="pgen.1005520.s012.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank Kevin Strange for the <italic>gpdh-1(kb24); gpdh-2(kb33)</italic> double mutant strain and Todd Lamitina for <italic>gpdh-2(kb33)</italic> strain. We acknowledge Maxime Bouchard and Laura Schmidt for kindly providing the <italic>Pax8-Cre</italic> and the <italic>Flcn</italic>
<sup><italic>flox/flox</italic></sup> C57BL/6 mice, respectively. We thank Christian Rocheleau for critical reading of the manuscript. We thank Mr. Ken Nguyen for his help in processing animals for electron microscopy. We acknowledge the <italic>Caenorhabditis</italic> Genetic Center for <italic>C</italic>. <italic>elegans</italic> strains.</p></ack><ref-list><title>References</title><ref id="pgen.1005520.ref001"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Brocker</surname><given-names>C</given-names></name>, <name><surname>Thompson</surname><given-names>DC</given-names></name>, <name><surname>Vasiliou</surname><given-names>V</given-names></name> (<year>2012</year>) <article-title>The role of hyperosmotic stress in inflammation and disease</article-title>. <source>Biomol Concepts</source>
<volume>3</volume>: <fpage>345</fpage>&#x02013;<lpage>364</lpage>.
<?supplied-pmid 22977648?><pub-id pub-id-type="pmid">22977648</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref002"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Burg</surname><given-names>MB</given-names></name>, <name><surname>Ferraris</surname><given-names>JD</given-names></name>, <name><surname>Dmitrieva</surname><given-names>NI</given-names></name> (<year>2007</year>) <article-title>Cellular response to hyperosmotic stresses</article-title>. <source>Physiol Rev</source>
<volume>87</volume>: <fpage>1441</fpage>&#x02013;<lpage>1474</lpage>.
<?supplied-pmid 17928589?><pub-id pub-id-type="pmid">17928589</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref003"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Yancey</surname><given-names>PH</given-names></name> (<year>2005</year>) <article-title>Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stresses</article-title>. <source>J Exp Biol</source>
<volume>208</volume>: <fpage>2819</fpage>&#x02013;<lpage>2830</lpage>.
<?supplied-pmid 16043587?><pub-id pub-id-type="pmid">16043587</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref004"><label>4</label><mixed-citation publication-type="journal">
<name><surname>O'Rourke</surname><given-names>SM</given-names></name>, <name><surname>Herskowitz</surname><given-names>I</given-names></name>, <name><surname>O'Shea</surname><given-names>EK</given-names></name> (<year>2002</year>) <article-title>Yeast go the whole HOG for the hyperosmotic response</article-title>. <source>Trends Genet</source>
<volume>18</volume>: <fpage>405</fpage>&#x02013;<lpage>412</lpage>.
<?supplied-pmid 12142009?><pub-id pub-id-type="pmid">12142009</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref005"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Lamitina</surname><given-names>ST</given-names></name>, <name><surname>Morrison</surname><given-names>R</given-names></name>, <name><surname>Moeckel</surname><given-names>GW</given-names></name>, <name><surname>Strange</surname><given-names>K</given-names></name> (<year>2004</year>) <article-title>Adaptation of the nematode <italic>Caenorhabditis elegans</italic> to extreme osmotic stress</article-title>. <source>Am J Physiol Cell Physiol</source>
<volume>286</volume>: <fpage>C785</fpage>&#x02013;<lpage>791</lpage>.
<?supplied-pmid 14644776?><pub-id pub-id-type="pmid">14644776</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref006"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Lamitina</surname><given-names>T</given-names></name>, <name><surname>Huang</surname><given-names>CG</given-names></name>, <name><surname>Strange</surname><given-names>K</given-names></name> (<year>2006</year>) <article-title>Genome-wide RNAi screening identifies protein damage as a regulator of osmoprotective gene expression</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>103</volume>: <fpage>12173</fpage>&#x02013;<lpage>12178</lpage>.
<?supplied-pmid 16880390?><pub-id pub-id-type="pmid">16880390</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref007"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Rohlfing</surname><given-names>AK</given-names></name>, <name><surname>Miteva</surname><given-names>Y</given-names></name>, <name><surname>Moronetti</surname><given-names>L</given-names></name>, <name><surname>He</surname><given-names>L</given-names></name>, <name><surname>Lamitina</surname><given-names>T</given-names></name> (<year>2011</year>) <article-title>The <italic>Caenorhabditis elegans</italic> mucin-like protein OSM-8 negatively regulates osmosensitive physiology via the transmembrane protein PTR-23</article-title>. <source>PLoS Genet</source>
<volume>7</volume>: <fpage>e1001267</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pgen.1001267">10.1371/journal.pgen.1001267</ext-link></comment>
<?supplied-pmid 21253570?><pub-id pub-id-type="pmid">21253570</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref008"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Rohlfing</surname><given-names>AK</given-names></name>, <name><surname>Miteva</surname><given-names>Y</given-names></name>, <name><surname>Hannenhalli</surname><given-names>S</given-names></name>, <name><surname>Lamitina</surname><given-names>T</given-names></name> (<year>2010</year>) <article-title>Genetic and physiological activation of osmosensitive gene expression mimics transcriptional signatures of pathogen infection in <italic>C</italic>. <italic>elegans</italic>
</article-title>. <source>PLoS One</source>
<volume>5</volume>: <fpage>e9010</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0009010">10.1371/journal.pone.0009010</ext-link></comment>
<?supplied-pmid 20126308?><pub-id pub-id-type="pmid">20126308</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref009"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Solomon</surname><given-names>A</given-names></name>, <name><surname>Bandhakavi</surname><given-names>S</given-names></name>, <name><surname>Jabbar</surname><given-names>S</given-names></name>, <name><surname>Shah</surname><given-names>R</given-names></name>, <name><surname>Beitel</surname><given-names>GJ</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>
<italic>Caenorhabditis elegans</italic> OSR-1 regulates behavioral and physiological responses to hyperosmotic environments</article-title>. <source>Genetics</source>
<volume>167</volume>: <fpage>161</fpage>&#x02013;<lpage>170</lpage>.
<?supplied-pmid 15166144?><pub-id pub-id-type="pmid">15166144</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref010"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Wheeler</surname><given-names>JM</given-names></name>, <name><surname>Thomas</surname><given-names>JH</given-names></name> (<year>2006</year>) <article-title>Identification of a novel gene family involved in osmotic stress response in <italic>Caenorhabditis elegans</italic>
</article-title>. <source>Genetics</source>
<volume>174</volume>: <fpage>1327</fpage>&#x02013;<lpage>1336</lpage>.<pub-id pub-id-type="pmid">16980399</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref011"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Hardie</surname><given-names>DG</given-names></name>, <name><surname>Ashford</surname><given-names>ML</given-names></name> (<year>2014</year>) <article-title>AMPK: regulating energy balance at the cellular and whole body levels</article-title>. <source>Physiology (Bethesda)</source>
<volume>29</volume>: <fpage>99</fpage>&#x02013;<lpage>107</lpage>.<pub-id pub-id-type="pmid">24583766</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref012"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Hornstein</surname><given-names>OP</given-names></name>, <name><surname>Knickenberg</surname><given-names>M</given-names></name> (<year>1975</year>) <article-title>Perifollicular fibromatosis cutis with polyps of the colon&#x02014;a cutaneo-intestinal syndrome sui generis</article-title>. <source>Arch Dermatol Res</source>
<volume>253</volume>: <fpage>161</fpage>&#x02013;<lpage>175</lpage>.
<?supplied-pmid 1200700?><pub-id pub-id-type="pmid">1200700</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref013"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Birt</surname><given-names>AR</given-names></name>, <name><surname>Hogg</surname><given-names>GR</given-names></name>, <name><surname>Dube</surname><given-names>WJ</given-names></name> (<year>1977</year>) <article-title>Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons</article-title>. <source>Arch Dermatol</source>
<volume>113</volume>: <fpage>1674</fpage>&#x02013;<lpage>1677</lpage>.
<?supplied-pmid 596896?><pub-id pub-id-type="pmid">596896</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref014"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Toro</surname><given-names>JR</given-names></name>, <name><surname>Glenn</surname><given-names>G</given-names></name>, <name><surname>Duray</surname><given-names>P</given-names></name>, <name><surname>Darling</surname><given-names>T</given-names></name>, <name><surname>Weirich</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>1999</year>) <article-title>Birt-Hogg-Dube syndrome: a novel marker of kidney neoplasia</article-title>. <source>Arch Dermatol</source>
<volume>135</volume>: <fpage>1195</fpage>&#x02013;<lpage>1202</lpage>.
<?supplied-pmid 10522666?><pub-id pub-id-type="pmid">10522666</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref015"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Pavlovich</surname><given-names>CP</given-names></name>, <name><surname>Walther</surname><given-names>MM</given-names></name>, <name><surname>Eyler</surname><given-names>RA</given-names></name>, <name><surname>Hewitt</surname><given-names>SM</given-names></name>, <name><surname>Zbar</surname><given-names>B</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Renal tumors in the Birt-Hogg-Dube syndrome</article-title>. <source>Am J Surg Pathol</source>
<volume>26</volume>: <fpage>1542</fpage>&#x02013;<lpage>1552</lpage>.
<?supplied-pmid 12459621?><pub-id pub-id-type="pmid">12459621</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref016"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Zbar</surname><given-names>B</given-names></name>, <name><surname>Alvord</surname><given-names>WG</given-names></name>, <name><surname>Glenn</surname><given-names>G</given-names></name>, <name><surname>Turner</surname><given-names>M</given-names></name>, <name><surname>Pavlovich</surname><given-names>CP</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>
<volume>11</volume>: <fpage>393</fpage>&#x02013;<lpage>400</lpage>.
<?supplied-pmid 11927500?><pub-id pub-id-type="pmid">11927500</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref017"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Tobino</surname><given-names>K</given-names></name>, <name><surname>Gunji</surname><given-names>Y</given-names></name>, <name><surname>Kurihara</surname><given-names>M</given-names></name>, <name><surname>Kunogi</surname><given-names>M</given-names></name>, <name><surname>Koike</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Characteristics of pulmonary cysts in Birt-Hogg-Dube syndrome: thin-section CT findings of the chest in 12 patients</article-title>. <source>Eur J Radiol</source>
<volume>77</volume>: <fpage>403</fpage>&#x02013;<lpage>409</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ejrad.2009.09.004">10.1016/j.ejrad.2009.09.004</ext-link></comment>
<?supplied-pmid 19782489?><pub-id pub-id-type="pmid">19782489</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref018"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Gupta</surname><given-names>P</given-names></name>, <name><surname>Eshaghi</surname><given-names>N</given-names></name>, <name><surname>Kamba</surname><given-names>TT</given-names></name>, <name><surname>Ghole</surname><given-names>V</given-names></name>, <name><surname>Garcia-Morales</surname><given-names>F</given-names></name> (<year>2007</year>) <article-title>Radiological findings in Birt-Hogg-Dube syndrome: a rare differential for pulmonary cysts and renal tumors</article-title>. <source>Clin Imaging</source>
<volume>31</volume>: <fpage>40</fpage>&#x02013;<lpage>43</lpage>.
<?supplied-pmid 17189846?><pub-id pub-id-type="pmid">17189846</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref019"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Kupres</surname><given-names>KA</given-names></name>, <name><surname>Krivda</surname><given-names>SJ</given-names></name>, <name><surname>Turiansky</surname><given-names>GW</given-names></name> (<year>2003</year>) <article-title>Numerous asymptomatic facial papules and multiple pulmonary cysts: a case of Birt-Hogg-Dube syndrome</article-title>. <source>Cutis</source>
<volume>72</volume>: <fpage>127</fpage>&#x02013;<lpage>131</lpage>.
<?supplied-pmid 12953936?><pub-id pub-id-type="pmid">12953936</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref020"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Furuya</surname><given-names>M</given-names></name>, <name><surname>Tanaka</surname><given-names>R</given-names></name>, <name><surname>Koga</surname><given-names>S</given-names></name>, <name><surname>Yatabe</surname><given-names>Y</given-names></name>, <name><surname>Gotoda</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Pulmonary cysts of Birt-Hogg-Dube syndrome: a clinicopathologic and immunohistochemical study of 9 families</article-title>. <source>Am J Surg Pathol</source>
<volume>36</volume>: <fpage>589</fpage>&#x02013;<lpage>600</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/PAS.0b013e3182475240">10.1097/PAS.0b013e3182475240</ext-link></comment>
<?supplied-pmid 22441547?><pub-id pub-id-type="pmid">22441547</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref021"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Van Denhove</surname><given-names>A</given-names></name>, <name><surname>Guillot-Pouget</surname><given-names>I</given-names></name>, <name><surname>Giraud</surname><given-names>S</given-names></name>, <name><surname>Isaac</surname><given-names>S</given-names></name>, <name><surname>Freymond</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2011</year>) [<article-title>Multiple spontaneous pneumothoraces revealing Birt-Hogg-Dube syndrome</article-title>]. <source>Rev Mal Respir</source>
<volume>28</volume>: <fpage>355</fpage>&#x02013;<lpage>359</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.rmr.2010.08.015">10.1016/j.rmr.2010.08.015</ext-link></comment>
<?supplied-pmid 21482341?><pub-id pub-id-type="pmid">21482341</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref022"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Petersson</surname><given-names>F</given-names></name>, <name><surname>Gatalica</surname><given-names>Z</given-names></name>, <name><surname>Grossmann</surname><given-names>P</given-names></name>, <name><surname>Perez Montiel</surname><given-names>MD</given-names></name>, <name><surname>Alvarado Cabrero</surname><given-names>I</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases</article-title>. <source>Virchows Arch</source>
<volume>456</volume>: <fpage>355</fpage>&#x02013;<lpage>365</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00428-010-0898-4">10.1007/s00428-010-0898-4</ext-link></comment>
<?supplied-pmid 20300772?><pub-id pub-id-type="pmid">20300772</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref023"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Koga</surname><given-names>S</given-names></name>, <name><surname>Furuya</surname><given-names>M</given-names></name>, <name><surname>Takahashi</surname><given-names>Y</given-names></name>, <name><surname>Tanaka</surname><given-names>R</given-names></name>, <name><surname>Yamaguchi</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Lung cysts in Birt-Hogg-Dube syndrome: histopathological characteristics and aberrant sequence repeats</article-title>. <source>Pathol Int</source>
<volume>59</volume>: <fpage>720</fpage>&#x02013;<lpage>728</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1440-1827.2009.02434.x">10.1111/j.1440-1827.2009.02434.x</ext-link></comment>
<?supplied-pmid 19788617?><pub-id pub-id-type="pmid">19788617</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref024"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Toro</surname><given-names>JR</given-names></name>, <name><surname>Wei</surname><given-names>MH</given-names></name>, <name><surname>Glenn</surname><given-names>GM</given-names></name>, <name><surname>Weinreich</surname><given-names>M</given-names></name>, <name><surname>Toure</surname><given-names>O</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: a new series of 50 families and a review of published reports</article-title>. <source>J Med Genet</source>
<volume>45</volume>: <fpage>321</fpage>&#x02013;<lpage>331</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/jmg.2007.054304">10.1136/jmg.2007.054304</ext-link></comment>
<?supplied-pmid 18234728?><pub-id pub-id-type="pmid">18234728</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref025"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Nickerson</surname><given-names>ML</given-names></name>, <name><surname>Warren</surname><given-names>MB</given-names></name>, <name><surname>Toro</surname><given-names>JR</given-names></name>, <name><surname>Matrosova</surname><given-names>V</given-names></name>, <name><surname>Glenn</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome</article-title>. <source>Cancer Cell</source>
<volume>2</volume>: <fpage>157</fpage>&#x02013;<lpage>164</lpage>.
<?supplied-pmid 12204536?><pub-id pub-id-type="pmid">12204536</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref026"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Baba</surname><given-names>M</given-names></name>, <name><surname>Hong</surname><given-names>SB</given-names></name>, <name><surname>Sharma</surname><given-names>N</given-names></name>, <name><surname>Warren</surname><given-names>MB</given-names></name>, <name><surname>Nickerson</surname><given-names>ML</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>103</volume>: <fpage>15552</fpage>&#x02013;<lpage>15557</lpage>.
<?supplied-pmid 17028174?><pub-id pub-id-type="pmid">17028174</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref027"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Hasumi</surname><given-names>H</given-names></name>, <name><surname>Baba</surname><given-names>M</given-names></name>, <name><surname>Hong</surname><given-names>SB</given-names></name>, <name><surname>Hasumi</surname><given-names>Y</given-names></name>, <name><surname>Huang</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Identification and characterization of a novel folliculin-interacting protein FNIP2</article-title>. <source>Gene</source>
<volume>415</volume>: <fpage>60</fpage>&#x02013;<lpage>67</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.gene.2008.02.022">10.1016/j.gene.2008.02.022</ext-link></comment>
<?supplied-pmid 18403135?><pub-id pub-id-type="pmid">18403135</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref028"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Possik</surname><given-names>E</given-names></name>, <name><surname>Jalali</surname><given-names>Z</given-names></name>, <name><surname>Nouet</surname><given-names>Y</given-names></name>, <name><surname>Yan</surname><given-names>M</given-names></name>, <name><surname>Gingras</surname><given-names>MC</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Folliculin regulates ampk-dependent autophagy and metabolic stress survival</article-title>. <source>PLoS Genet</source>
<volume>10</volume>: <fpage>e1004273</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pgen.1004273">10.1371/journal.pgen.1004273</ext-link></comment>
<?supplied-pmid 24763318?><pub-id pub-id-type="pmid">24763318</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref029"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Yan</surname><given-names>M</given-names></name>, <name><surname>Gingras</surname><given-names>MC</given-names></name>, <name><surname>Dunlop</surname><given-names>EA</given-names></name>, <name><surname>Nouet</surname><given-names>Y</given-names></name>, <name><surname>Dupuy</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation</article-title>. <source>J Clin Invest</source>.</mixed-citation></ref><ref id="pgen.1005520.ref030"><label>30</label><mixed-citation publication-type="other">Possik et al. Manuscript in preparation.</mixed-citation></ref><ref id="pgen.1005520.ref031"><label>31</label><mixed-citation publication-type="other">Wormatlas <ext-link ext-link-type="uri" xlink:href="http://wwwwormatlasorg/dauer/muscle/Musframesethtml">http://wwwwormatlasorg/dauer/muscle/Musframesethtml</ext-link>.</mixed-citation></ref><ref id="pgen.1005520.ref032"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Frazier</surname><given-names>HN</given-names><suffix>3rd</suffix></name>, <name><surname>Roth</surname><given-names>MB</given-names></name> (<year>2009</year>) <article-title>Adaptive sugar provisioning controls survival of <italic>C</italic>. <italic>elegans</italic> embryos in adverse environments</article-title>. <source>Curr Biol</source>
<volume>19</volume>: <fpage>859</fpage>&#x02013;<lpage>863</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cub.2009.03.066">10.1016/j.cub.2009.03.066</ext-link></comment>
<?supplied-pmid 19398339?><pub-id pub-id-type="pmid">19398339</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref033"><label>33</label><mixed-citation publication-type="journal">
<name><surname>LaMacchia</surname><given-names>JC</given-names></name>, <name><surname>Roth</surname><given-names>MB</given-names></name> (<year>2015</year>) <article-title>Aquaporins 2 and 4 Regulate Glycogen Metabolism and Survival during Hyposmotic-Anoxic Stress in <italic>Caenorhabditis Elegans</italic>
</article-title>. <source>Am J Physiol Cell Physiol: ajpcell 00131 02015</source>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1152/ajpcell.00131.2015">10.1152/ajpcell.00131.2015</ext-link></comment>
<?supplied-pmid 26017147?><pub-id pub-id-type="pmid">26017147</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref034"><label>34</label><mixed-citation publication-type="journal">
<name><surname>LaMacchia</surname><given-names>JC</given-names></name>, <name><surname>Frazier</surname><given-names>HN</given-names><suffix>3rd</suffix></name>, <name><surname>Roth</surname><given-names>MB</given-names></name> (<year>2015</year>) <article-title>Glycogen Fuels Survival During Hyposmotic-Anoxic Stress in <italic>Caenorhabditis elegans</italic>
</article-title>. <source>Genetics</source>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1534/genetics.115.179416">10.1534/genetics.115.179416</ext-link></comment>
<?supplied-pmid 26116152?><pub-id pub-id-type="pmid">26116152</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref035"><label>35</label><mixed-citation publication-type="book">
<name><surname>Braeckman</surname><given-names>BP</given-names></name> (<year>2009</year>) <source>Intermediary metabolism</source>. In: <name><surname>Koen Houthoofd</surname><given-names>JRV</given-names></name>, editor. <day>16</day>
<month>2</month> 2009 ed. <publisher-name>wormbook</publisher-name>.</mixed-citation></ref><ref id="pgen.1005520.ref036"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Barnes</surname><given-names>K</given-names></name>, <name><surname>Ingram</surname><given-names>JC</given-names></name>, <name><surname>Porras</surname><given-names>OH</given-names></name>, <name><surname>Barros</surname><given-names>LF</given-names></name>, <name><surname>Hudson</surname><given-names>ER</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK)</article-title>. <source>J Cell Sci</source>
<volume>115</volume>: <fpage>2433</fpage>&#x02013;<lpage>2442</lpage>.
<?supplied-pmid 12006627?><pub-id pub-id-type="pmid">12006627</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref037"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Sanz</surname><given-names>P</given-names></name> (<year>2003</year>) <article-title>Snf1 protein kinase: a key player in the response to cellular stress in yeast</article-title>. <source>Biochem Soc Trans</source>
<volume>31</volume>: <fpage>178</fpage>&#x02013;<lpage>181</lpage>.
<?supplied-pmid 12546680?><pub-id pub-id-type="pmid">12546680</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref038"><label>38</label><mixed-citation publication-type="journal">
<name><surname>Mair</surname><given-names>W</given-names></name>, <name><surname>Morantte</surname><given-names>I</given-names></name>, <name><surname>Rodrigues</surname><given-names>AP</given-names></name>, <name><surname>Manning</surname><given-names>G</given-names></name>, <name><surname>Montminy</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB</article-title>. <source>Nature</source>
<volume>470</volume>: <fpage>404</fpage>&#x02013;<lpage>408</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature09706">10.1038/nature09706</ext-link></comment>
<?supplied-pmid 21331044?><pub-id pub-id-type="pmid">21331044</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref039"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Apfeld</surname><given-names>J</given-names></name>, <name><surname>O'Connor</surname><given-names>G</given-names></name>, <name><surname>McDonagh</surname><given-names>T</given-names></name>, <name><surname>DiStefano</surname><given-names>PS</given-names></name>, <name><surname>Curtis</surname><given-names>R</given-names></name> (<year>2004</year>) <article-title>The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in <italic>C</italic>. <italic>elegans</italic>
</article-title>. <source>Genes Dev</source>
<volume>18</volume>: <fpage>3004</fpage>&#x02013;<lpage>3009</lpage>.
<?supplied-pmid 15574588?><pub-id pub-id-type="pmid">15574588</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref040"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Schulz</surname><given-names>TJ</given-names></name>, <name><surname>Zarse</surname><given-names>K</given-names></name>, <name><surname>Voigt</surname><given-names>A</given-names></name>, <name><surname>Urban</surname><given-names>N</given-names></name>, <name><surname>Birringer</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Glucose restriction extends <italic>Caenorhabditis elegans</italic> life span by inducing mitochondrial respiration and increasing oxidative stress</article-title>. <source>Cell Metab</source>
<volume>6</volume>: <fpage>280</fpage>&#x02013;<lpage>293</lpage>.
<?supplied-pmid 17908557?><pub-id pub-id-type="pmid">17908557</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref041"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Fukuyama</surname><given-names>M</given-names></name>, <name><surname>Sakuma</surname><given-names>K</given-names></name>, <name><surname>Park</surname><given-names>R</given-names></name>, <name><surname>Kasuga</surname><given-names>H</given-names></name>, <name><surname>Nagaya</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>
<italic>C</italic>. <italic>elegans</italic> AMPKs promote survival and arrest germline development during nutrient stress</article-title>. <source>Biol Open</source>
<volume>1</volume>: <fpage>929</fpage>&#x02013;<lpage>936</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1242/bio.2012836">10.1242/bio.2012836</ext-link></comment>
<?supplied-pmid 23213370?><pub-id pub-id-type="pmid">23213370</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref042"><label>42</label><mixed-citation publication-type="journal">
<name><surname>LaRue</surname><given-names>BL</given-names></name>, <name><surname>Padilla</surname><given-names>PA</given-names></name> (<year>2011</year>) <article-title>Environmental and genetic preconditioning for long-term anoxia responses requires AMPK in <italic>Caenorhabditis elegans</italic>
</article-title>. <source>PLoS One</source>
<volume>6</volume>: <fpage>e16790</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0016790">10.1371/journal.pone.0016790</ext-link></comment>
<?supplied-pmid 21304820?><pub-id pub-id-type="pmid">21304820</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref043"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Lee</surname><given-names>H</given-names></name>, <name><surname>Cho</surname><given-names>JS</given-names></name>, <name><surname>Lambacher</surname><given-names>N</given-names></name>, <name><surname>Lee</surname><given-names>J</given-names></name>, <name><surname>Lee</surname><given-names>SJ</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>The Caenorhabditis elegans AMP-activated protein kinase AAK-2 is phosphorylated by LKB1 and is required for resistance to oxidative stress and for normal motility and foraging behavior</article-title>. <source>J Biol Chem</source>
<volume>283</volume>: <fpage>14988</fpage>&#x02013;<lpage>14993</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M709115200">10.1074/jbc.M709115200</ext-link></comment>
<?supplied-pmid 18408008?><pub-id pub-id-type="pmid">18408008</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref044"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Carling</surname><given-names>D</given-names></name>, <name><surname>Hardie</surname><given-names>DG</given-names></name> (<year>1989</year>) <article-title>The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase</article-title>. <source>Biochim Biophys Acta</source>
<volume>1012</volume>: <fpage>81</fpage>&#x02013;<lpage>86</lpage>.
<?supplied-pmid 2567185?><pub-id pub-id-type="pmid">2567185</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref045"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Jorgensen</surname><given-names>SB</given-names></name>, <name><surname>Nielsen</surname><given-names>JN</given-names></name>, <name><surname>Birk</surname><given-names>JB</given-names></name>, <name><surname>Olsen</surname><given-names>GS</given-names></name>, <name><surname>Viollet</surname><given-names>B</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>The alpha2-5'AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading</article-title>. <source>Diabetes</source>
<volume>53</volume>: <fpage>3074</fpage>&#x02013;<lpage>3081</lpage>.
<?supplied-pmid 15561936?><pub-id pub-id-type="pmid">15561936</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref046"><label>46</label><mixed-citation publication-type="journal">
<name><surname>Wojtaszewski</surname><given-names>JF</given-names></name>, <name><surname>Jorgensen</surname><given-names>SB</given-names></name>, <name><surname>Hellsten</surname><given-names>Y</given-names></name>, <name><surname>Hardie</surname><given-names>DG</given-names></name>, <name><surname>Richter</surname><given-names>EA</given-names></name> (<year>2002</year>) <article-title>Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle</article-title>. <source>Diabetes</source>
<volume>51</volume>: <fpage>284</fpage>&#x02013;<lpage>292</lpage>.
<?supplied-pmid 11812734?><pub-id pub-id-type="pmid">11812734</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref047"><label>47</label><mixed-citation publication-type="journal">
<name><surname>Miyamoto</surname><given-names>L</given-names></name>, <name><surname>Toyoda</surname><given-names>T</given-names></name>, <name><surname>Hayashi</surname><given-names>T</given-names></name>, <name><surname>Yonemitsu</surname><given-names>S</given-names></name>, <name><surname>Nakano</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Effect of acute activation of 5'-AMP-activated protein kinase on glycogen regulation in isolated rat skeletal muscle</article-title>. <source>J Appl Physiol (1985)</source>
<volume>102</volume>: <fpage>1007</fpage>&#x02013;<lpage>1013</lpage>.<pub-id pub-id-type="pmid">17122373</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref048"><label>48</label><mixed-citation publication-type="journal">
<name><surname>Hunter</surname><given-names>RW</given-names></name>, <name><surname>Treebak</surname><given-names>JT</given-names></name>, <name><surname>Wojtaszewski</surname><given-names>JF</given-names></name>, <name><surname>Sakamoto</surname><given-names>K</given-names></name> (<year>2011</year>) <article-title>Molecular mechanism by which AMP-activated protein kinase activation promotes glycogen accumulation in muscle</article-title>. <source>Diabetes</source>
<volume>60</volume>: <fpage>766</fpage>&#x02013;<lpage>774</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2337/db10-1148">10.2337/db10-1148</ext-link></comment>
<?supplied-pmid 21282366?><pub-id pub-id-type="pmid">21282366</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref049"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Aschenbach</surname><given-names>WG</given-names></name>, <name><surname>Hirshman</surname><given-names>MF</given-names></name>, <name><surname>Fujii</surname><given-names>N</given-names></name>, <name><surname>Sakamoto</surname><given-names>K</given-names></name>, <name><surname>Howlett</surname><given-names>KF</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Effect of AICAR treatment on glycogen metabolism in skeletal muscle</article-title>. <source>Diabetes</source>
<volume>51</volume>: <fpage>567</fpage>&#x02013;<lpage>573</lpage>.
<?supplied-pmid 11872652?><pub-id pub-id-type="pmid">11872652</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref050"><label>50</label><mixed-citation publication-type="journal">
<name><surname>Luptak</surname><given-names>I</given-names></name>, <name><surname>Shen</surname><given-names>M</given-names></name>, <name><surname>He</surname><given-names>H</given-names></name>, <name><surname>Hirshman</surname><given-names>MF</given-names></name>, <name><surname>Musi</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Aberrant activation of AMP-activated protein kinase remodels metabolic network in favor of cardiac glycogen storage</article-title>. <source>J Clin Invest</source>
<volume>117</volume>: <fpage>1432</fpage>&#x02013;<lpage>1439</lpage>.
<?supplied-pmid 17431505?><pub-id pub-id-type="pmid">17431505</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref051"><label>51</label><mixed-citation publication-type="journal">
<name><surname>Arad</surname><given-names>M</given-names></name>, <name><surname>Benson</surname><given-names>DW</given-names></name>, <name><surname>Perez-Atayde</surname><given-names>AR</given-names></name>, <name><surname>McKenna</surname><given-names>WJ</given-names></name>, <name><surname>Sparks</surname><given-names>EA</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy</article-title>. <source>J Clin Invest</source>
<volume>109</volume>: <fpage>357</fpage>&#x02013;<lpage>362</lpage>.
<?supplied-pmid 11827995?><pub-id pub-id-type="pmid">11827995</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref052"><label>52</label><mixed-citation publication-type="journal">
<name><surname>Ahmad</surname><given-names>F</given-names></name>, <name><surname>Arad</surname><given-names>M</given-names></name>, <name><surname>Musi</surname><given-names>N</given-names></name>, <name><surname>He</surname><given-names>H</given-names></name>, <name><surname>Wolf</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy</article-title>. <source>Circulation</source>
<volume>112</volume>: <fpage>3140</fpage>&#x02013;<lpage>3148</lpage>.
<?supplied-pmid 16275868?><pub-id pub-id-type="pmid">16275868</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref053"><label>53</label><mixed-citation publication-type="journal">
<name><surname>Zou</surname><given-names>L</given-names></name>, <name><surname>Shen</surname><given-names>M</given-names></name>, <name><surname>Arad</surname><given-names>M</given-names></name>, <name><surname>He</surname><given-names>H</given-names></name>, <name><surname>Lofgren</surname><given-names>B</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>N488I mutation of the gamma2-subunit results in bidirectional changes in AMP-activated protein kinase activity</article-title>. <source>Circ Res</source>
<volume>97</volume>: <fpage>323</fpage>&#x02013;<lpage>328</lpage>.
<?supplied-pmid 16051890?><pub-id pub-id-type="pmid">16051890</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref054"><label>54</label><mixed-citation publication-type="journal">
<name><surname>Wang</surname><given-names>Z</given-names></name>, <name><surname>Wilson</surname><given-names>WA</given-names></name>, <name><surname>Fujino</surname><given-names>MA</given-names></name>, <name><surname>Roach</surname><given-names>PJ</given-names></name> (<year>2001</year>) <article-title>Antagonistic controls of autophagy and glycogen accumulation by Snf1p, the yeast homolog of AMP-activated protein kinase, and the cyclin-dependent kinase Pho85p</article-title>. <source>Mol Cell Biol</source>
<volume>21</volume>: <fpage>5742</fpage>&#x02013;<lpage>5752</lpage>.
<?supplied-pmid 11486014?><pub-id pub-id-type="pmid">11486014</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref055"><label>55</label><mixed-citation publication-type="journal">
<name><surname>Yu</surname><given-names>H</given-names></name>, <name><surname>Hirshman</surname><given-names>MF</given-names></name>, <name><surname>Fujii</surname><given-names>N</given-names></name>, <name><surname>Pomerleau</surname><given-names>JM</given-names></name>, <name><surname>Peter</surname><given-names>LE</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase gamma3-subunit differentially regulates glycogen accumulation</article-title>. <source>Am J Physiol Endocrinol Metab</source>
<volume>291</volume>: <fpage>E557</fpage>&#x02013;<lpage>565</lpage>.
<?supplied-pmid 16638825?><pub-id pub-id-type="pmid">16638825</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref056"><label>56</label><mixed-citation publication-type="journal">
<name><surname>Milan</surname><given-names>D</given-names></name>, <name><surname>Jeon</surname><given-names>JT</given-names></name>, <name><surname>Looft</surname><given-names>C</given-names></name>, <name><surname>Amarger</surname><given-names>V</given-names></name>, <name><surname>Robic</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle</article-title>. <source>Science</source>
<volume>288</volume>: <fpage>1248</fpage>&#x02013;<lpage>1251</lpage>.
<?supplied-pmid 10818001?><pub-id pub-id-type="pmid">10818001</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref057"><label>57</label><mixed-citation publication-type="journal">
<name><surname>Lapierre</surname><given-names>LR</given-names></name>, <name><surname>Hansen</surname><given-names>M</given-names></name> (<year>2012</year>) <article-title>Lessons from <italic>C</italic>. <italic>elegans</italic>: signaling pathways for longevity</article-title>. <source>Trends Endocrinol Metab</source>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.tem.2012.07.007">10.1016/j.tem.2012.07.007</ext-link></comment>
<?supplied-pmid 22939742?><pub-id pub-id-type="pmid">22939742</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref058"><label>58</label><mixed-citation publication-type="journal">
<name><surname>Sheikh-Hamad</surname><given-names>D</given-names></name>, <name><surname>Gustin</surname><given-names>MC</given-names></name> (<year>2004</year>) <article-title>MAP kinases and the adaptive response to hypertonicity: functional preservation from yeast to mammals</article-title>. <source>Am J Physiol Renal Physiol</source>
<volume>287</volume>: <fpage>F1102</fpage>&#x02013;<lpage>1110</lpage>.
<?supplied-pmid 15522988?><pub-id pub-id-type="pmid">15522988</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref059"><label>59</label><mixed-citation publication-type="journal">
<name><surname>Favaro</surname><given-names>E</given-names></name>, <name><surname>Bensaad</surname><given-names>K</given-names></name>, <name><surname>Chong</surname><given-names>MG</given-names></name>, <name><surname>Tennant</surname><given-names>DA</given-names></name>, <name><surname>Ferguson</surname><given-names>DJ</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells</article-title>. <source>Cell Metab</source>
<volume>16</volume>: <fpage>751</fpage>&#x02013;<lpage>764</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cmet.2012.10.017">10.1016/j.cmet.2012.10.017</ext-link></comment>
<?supplied-pmid 23177934?><pub-id pub-id-type="pmid">23177934</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref060"><label>60</label><mixed-citation publication-type="journal">
<name><surname>Rousset</surname><given-names>M</given-names></name>, <name><surname>Zweibaum</surname><given-names>A</given-names></name>, <name><surname>Fogh</surname><given-names>J</given-names></name> (<year>1981</year>) <article-title>Presence of glycogen and growth-related variations in 58 cultured human tumor cell lines of various tissue origins</article-title>. <source>Cancer Res</source>
<volume>41</volume>: <fpage>1165</fpage>&#x02013;<lpage>1170</lpage>.
<?supplied-pmid 7459858?><pub-id pub-id-type="pmid">7459858</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref061"><label>61</label><mixed-citation publication-type="journal">
<name><surname>Bouchard</surname><given-names>M</given-names></name>, <name><surname>Souabni</surname><given-names>A</given-names></name>, <name><surname>Busslinger</surname><given-names>M</given-names></name> (<year>2004</year>) <article-title>Tissue-specific expression of cre recombinase from the Pax8 locus</article-title>. <source>Genesis</source>
<volume>38</volume>: <fpage>105</fpage>&#x02013;<lpage>109</lpage>.
<?supplied-pmid 15048807?><pub-id pub-id-type="pmid">15048807</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref062"><label>62</label><mixed-citation publication-type="journal">
<name><surname>Hasumi</surname><given-names>H</given-names></name>, <name><surname>Baba</surname><given-names>M</given-names></name>, <name><surname>Hasumi</surname><given-names>Y</given-names></name>, <name><surname>Huang</surname><given-names>Y</given-names></name>, <name><surname>Oh</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN</article-title>. <source>J Natl Cancer Inst</source>
<volume>104</volume>: <fpage>1750</fpage>&#x02013;<lpage>1764</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/jnci/djs418">10.1093/jnci/djs418</ext-link></comment>
<?supplied-pmid 23150719?><pub-id pub-id-type="pmid">23150719</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref063"><label>63</label><mixed-citation publication-type="journal">
<name><surname>Baba</surname><given-names>M</given-names></name>, <name><surname>Keller</surname><given-names>JR</given-names></name>, <name><surname>Sun</surname><given-names>HW</given-names></name>, <name><surname>Resch</surname><given-names>W</given-names></name>, <name><surname>Kuchen</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dube syndrome is required for murine B-cell development</article-title>. <source>Blood</source>
<volume>120</volume>: <fpage>1254</fpage>&#x02013;<lpage>1261</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1182/blood-2012-02-410407">10.1182/blood-2012-02-410407</ext-link></comment>
<?supplied-pmid 22709692?><pub-id pub-id-type="pmid">22709692</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref064"><label>64</label><mixed-citation publication-type="journal">
<name><surname>Zois</surname><given-names>CE</given-names></name>, <name><surname>Favaro</surname><given-names>E</given-names></name>, <name><surname>Harris</surname><given-names>AL</given-names></name> (<year>2014</year>) <article-title>Glycogen metabolism in cancer</article-title>. <source>Biochem Pharmacol</source>
<volume>92</volume>: <fpage>3</fpage>&#x02013;<lpage>11</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.bcp.2014.09.001">10.1016/j.bcp.2014.09.001</ext-link></comment>
<?supplied-pmid 25219323?><pub-id pub-id-type="pmid">25219323</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref065"><label>65</label><mixed-citation publication-type="journal">
<name><surname>Slattery</surname><given-names>ML</given-names></name>, <name><surname>Lundgreen</surname><given-names>A</given-names></name>, <name><surname>Bondurant</surname><given-names>KL</given-names></name>, <name><surname>Wolff</surname><given-names>RK</given-names></name> (<year>2011</year>) <article-title>Tumor necrosis factor-related genes and colon and rectal cancer</article-title>. <source>Int J Mol Epidemiol Genet</source>
<volume>2</volume>: <fpage>328</fpage>&#x02013;<lpage>338</lpage>.
<?supplied-pmid 22199996?><pub-id pub-id-type="pmid">22199996</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref066"><label>66</label><mixed-citation publication-type="journal">
<name><surname>Li</surname><given-names>JT</given-names></name>, <name><surname>Wang</surname><given-names>LF</given-names></name>, <name><surname>Zhao</surname><given-names>YL</given-names></name>, <name><surname>Yang</surname><given-names>T</given-names></name>, <name><surname>Li</surname><given-names>W</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Nuclear factor of activated T cells 5 maintained by Hotair suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis</article-title>. <source>Breast Cancer Res</source>
<volume>16</volume>: <fpage>454</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/s13058-014-0454-2">10.1186/s13058-014-0454-2</ext-link></comment>
<?supplied-pmid 25311085?><pub-id pub-id-type="pmid">25311085</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref067"><label>67</label><mixed-citation publication-type="journal">
<name><surname>Kuper</surname><given-names>C</given-names></name>, <name><surname>Beck</surname><given-names>FX</given-names></name>, <name><surname>Neuhofer</surname><given-names>W</given-names></name> (<year>2014</year>) <article-title>NFAT5-mediated expression of S100A4 contributes to proliferation and migration of renal carcinoma cells</article-title>. <source>Front Physiol</source>
<volume>5</volume>: <fpage>293</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3389/fphys.2014.00293">10.3389/fphys.2014.00293</ext-link></comment>
<?supplied-pmid 25152734?><pub-id pub-id-type="pmid">25152734</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref068"><label>68</label><mixed-citation publication-type="journal">
<name><surname>Brenner</surname><given-names>S</given-names></name> (<year>1974</year>) <article-title>The genetics of <italic>Caenorhabditis elegans</italic>
</article-title>. <source>Genetics</source>
<volume>77</volume>: <fpage>71</fpage>&#x02013;<lpage>94</lpage>.
<?supplied-pmid 4366476?><pub-id pub-id-type="pmid">4366476</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref069"><label>69</label><mixed-citation publication-type="journal">
<name><surname>Kamath</surname><given-names>RS</given-names></name>, <name><surname>Martinez-Campos</surname><given-names>M</given-names></name>, <name><surname>Zipperlen</surname><given-names>P</given-names></name>, <name><surname>Fraser</surname><given-names>AG</given-names></name>, <name><surname>Ahringer</surname><given-names>J</given-names></name> (<year>2001</year>) <article-title>Effectiveness of specific RNA-mediated interference through ingested double-stranded RNA in <italic>Caenorhabditis elegans</italic>
</article-title>. <source>Genome Biology</source>
<volume>2</volume>.</mixed-citation></ref><ref id="pgen.1005520.ref070"><label>70</label><mixed-citation publication-type="journal">
<name><surname>Hall</surname><given-names>DH</given-names></name> (<year>1995</year>) <article-title>Electron microscopy and three-dimensional image reconstruction</article-title>. <source>Methods in Cell Biology</source>, <volume>Vol 48</volume> : <fpage>395</fpage>&#x02013;<lpage>436</lpage>.<pub-id pub-id-type="pmid">8531736</pub-id></mixed-citation></ref><ref id="pgen.1005520.ref071"><label>71</label><mixed-citation publication-type="journal">
<name><surname>Preston</surname><given-names>RS</given-names></name>, <name><surname>Philp</surname><given-names>A</given-names></name>, <name><surname>Claessens</surname><given-names>T</given-names></name>, <name><surname>Gijezen</surname><given-names>L</given-names></name>, <name><surname>Dydensborg</surname><given-names>AB</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Absence of the Birt-Hogg-Dube gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility</article-title>. <source>Oncogene</source>
<volume>30</volume>: <fpage>1159</fpage>&#x02013;<lpage>1173</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/onc.2010.497">10.1038/onc.2010.497</ext-link></comment>
<?supplied-pmid 21057536?><pub-id pub-id-type="pmid">21057536</pub-id></mixed-citation></ref></ref-list></back></article>